BlaOXA-48 Genotypic Detection of Carbapenem Resistance in Isolates of Pseudomonas Aeruginosa

Objective: To determine the prevalence of carbapenem resistance in strains of Pseudomonas aeruginosa at a molecular level by detecting OXA-48 gene which transcribe for resistance to the antibiotic carbapenem among indoor patients of a tertiary care hospital Karachi. Study Design and Setting: This observational cross-sectional study was conducted from September 2018 to May 2019 at PNS Shifa hospital of Karachi. Methodology: Total 140 strains of Pseudomonas aeruginosa were received and cultured from pus samples. These samples were collected from different wards like medicine, surgery, burn unit, ICU, ENT, plastic surgery, paedriatic and family ward. Carbapenem resistance was screened phenotypically by AST (Antibiotic susceptibility test), MHT (Modified Hodge test) and mCIM (Modified Carbapenem Inactivation Method) in all samples. Only in resistant cases OXA-48 gene was detected by real time PCR (polymerase chain reaction). Data was analyzed by following the proper loading sequence on product specification sheet. Data was statistically analyzed by SPSS version 23.0. Results were expressed as frequencies (percentages). Results: Out of 140, 17 (12%) were found to be resistant to carbapenem by AST, 20 (14%) by MHT, 25 (17.8%) by mCIM. Out of 25 resistant cases, 4 (16%) presence of OXA-48 gene by real time PCR were detected. Conclusion: OXA-48 gene showed 16% carbapenem resistance in this study. Pseudomonas aeruginosa is an opportunistic organism which causes multidrug resistance especially in hospitalized patients. Carbapenem is the last resort for serious infections

[1]  L. Westblade,et al.  Blood-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Carbapenemase-Producing Enterobacteriaceae Directly from Positive Blood Culture Broths , 2019, Journal of Clinical Microbiology.

[2]  K. Anderson,et al.  Evaluation of the RAPIDEC CARBA NP, Conventional CarbaNP, and the Modified Carbapenem Inactivation Method (mCIM) Tests for Phenotypic Detection of Carbapenemase-Producing Organisms , 2018, American Journal of Clinical Pathology.

[3]  J. Faghri,et al.  The emergence of blaOXA-48 and blaNDM among ESBL-producing Klebsiella pneumoniae in clinical isolates of a tertiary hospital in Iran. , 2018, Acta microbiologica et immunologica Hungarica.

[4]  M. Kazi,et al.  Rapid detection of the commonly encountered carbapenemases (New Delhi metallo-β-lactamase, OXA-48/181) directly from various clinical samples using multiplex real-time polymerase chain reaction assay , 2018, Indian Journal of Medical Microbiology.

[5]  S. Mohamed,et al.  Carbapenem Resistant Pseudomonas aeruginosa Clinical Isolates in Sudan , 2018 .

[6]  T. Naas,et al.  Molecular Characterization of OXA-198 Carbapenemase-Producing Pseudomonas aeruginosa Clinical Isolates , 2018, Antimicrobial Agents and Chemotherapy.

[7]  S. Mohite,et al.  Closing the Gap Between Phenotypic and Genotypic Detection of Carbapenem Resistant Enterobacteriaceae by New Modified Carbapenem Inactivation Method , 2018 .

[8]  M. Rupnik,et al.  Low overlap between carbapenem resistant Pseudomonas aeruginosa genotypes isolated from hospitalized patients and wastewater treatment plants , 2017, PloS one.

[9]  R. Thomson,,et al.  Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae , 2017, Journal of Clinical Microbiology.

[10]  R. Roodsari,et al.  Fast and specific detection of Pseudomonas Aeruginosa from other pseudomonas species by PCR. , 2016 .

[11]  C. Clancy,et al.  Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure , 2016, Antimicrobial Agents and Chemotherapy.

[12]  W. Judd,et al.  Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa-infected patients. , 2016, American journal of infection control.

[13]  Yan-ping Luo,et al.  Nosocomial Outbreak of OXA-48-Producing Klebsiella pneumoniae in a Chinese Hospital: Clonal Transmission of ST147 and ST383 , 2016, PloS one.

[14]  R. Khatun,et al.  Detection of OXA-181/OXA-48 carbapenemase producing Enterobacteriaceae in Bangladesh , 2016 .

[15]  N. Aksu,et al.  Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey , 2016, Annals of Clinical Microbiology and Antimicrobials.

[16]  B. Veeraraghavan,et al.  Laboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden Threat , 2016, Journal of global infectious diseases.

[17]  G. Jami Al-Ahmadi,et al.  Fast and specific detection of Pseudomonas Aeruginosa from other pseudomonas species by PCR. , 2016, Annals of burns and fire disasters.

[18]  F. Eftekhar,et al.  Correlation of Oxacillinase Gene Carriage With the Genetic Fingerprints of Imipenem-Resistant Clinical Isolates of Acinetobacter baumannii , 2015, Jundishapur journal of microbiology.

[19]  M. Naeem,et al.  SENSITIVITY PATTERNS OF PSEUDOMONAS AERUGINOSA ISOLATES OBTAINED FROM CLINICAL SPECIMENS IN PESHAWAR. , 2015, Journal of Ayub Medical College, Abbottabad : JAMC.

[20]  C. L. Ventola.  The antibiotic resistance crisis: part 1: causes and threats. , 2015, P & T : a peer-reviewed journal for formulary management.

[21]  Wonkeun Song,et al.  Combined Use of the Modified Hodge Test and Carbapenemase Inhibition Test for Detection of Carbapenemase-Producing Enterobacteriaceae and Metallo-β-Lactamase-Producing Pseudomonas spp. , 2015, Annals of laboratory medicine.

[22]  Yonatan H. Grad,et al.  Origin and Proliferation of Multiple-Drug Resistance in Bacterial Pathogens , 2015, Microbiology and Molecular Reviews.

[23]  A. Fluit,et al.  Multi-centre evaluation of real-time multiplex PCR for detection of carbapenemase genes OXA-48, VIM, IMP, NDM and KPC , 2014, BMC Infectious Diseases.

[24]  S. Mohanty,et al.  Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp. , 2013, Journal of infection in developing countries.

[25]  Z. Aktaş,et al.  Carbapenem-Hydrolyzing Oxacillinase, OXA-48, Persists in Klebsiella pneumoniae in Istanbul, Turkey , 2008, Chemotherapy.

[26]  E. Jenwitheesuk,et al.  Annals of Clinical Microbiology and Antimicrobials , 2003 .